News coverage about InfuSystem Holdings (NYSE:INFU) has trended somewhat positive on Friday, according to Accern Sentiment. The research group ranks the sentiment of news coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. InfuSystem Holdings earned a media sentiment score of 0.02 on Accern’s scale. Accern also gave press coverage about the medical instruments supplier an impact score of 45.2269440748325 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.
InfuSystem Holdings (INFU) traded up 8.33% during mid-day trading on Friday, hitting $1.95. 16,444 shares of the stock were exchanged. The firm’s market cap is $44.37 million. InfuSystem Holdings has a 12-month low of $1.20 and a 12-month high of $3.04. The company has a 50 day moving average of $1.81 and a 200 day moving average of $1.95.
InfuSystem Holdings (NYSE:INFU) last issued its earnings results on Wednesday, August 9th. The medical instruments supplier reported ($0.02) EPS for the quarter. The firm had revenue of $16.94 million during the quarter. InfuSystem Holdings had a negative net margin of 8.37% and a negative return on equity of 11.82%. On average, equities analysts anticipate that InfuSystem Holdings will post $0.24 earnings per share for the current fiscal year.
In related news, Director Meridian Ohc Partners, Lp bought 56,670 shares of the company’s stock in a transaction dated Wednesday, August 16th. The stock was acquired at an average cost of $1.84 per share, with a total value of $104,272.80. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, Director Darrell B. Montgomery bought 25,000 shares of the company’s stock in a transaction dated Monday, August 14th. The stock was bought at an average cost of $1.88 per share, with a total value of $47,000.00. Following the completion of the acquisition, the director now owns 12,000 shares in the company, valued at approximately $22,560. The disclosure for this purchase can be found here. In the last 90 days, insiders have purchased 120,759 shares of company stock valued at $216,576.
InfuSystem Holdings Company Profile
InfuSystem Holdings, Inc is a provider of infusion pumps and related products and services for patients in the home, oncology clinics, ambulatory surgery centers and other sites of care. The Company delivers local, field-based customer support and also operates pump service and repair Centers of Excellence in Michigan, Kansas, California, Texas and Ontario, Canada.
Receive News & Ratings for InfuSystem Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InfuSystem Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.